EXHIBIT 23.8
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
We consent to the reference to our firm under the caption "Experts" and to the
use of our report dated February 4, 2000, with respect to the financial
statements of Signal Pharmaceuticals, Inc. that is made part of Amendment No. 1
to the Registration Statement (Form S-4) and Prospectus of Celgene Corporation
for the registration of shares of its common stock.
/s/ Ernst & Young LLP
ERNST & YOUNG LLP
August 4, 2000
San Diego, California
